Orexo AB (OMX:ORX)

European company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ORX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ORX

  • Market CapSEK0.000m
  • SymbolOMX:ORX
  • IndustryHealthcare
  • SectorDrug Manufacturers - Specialty & Generic
  • Currency
  • ISINSE0000736415

Company Profile

Orexo AB develops pharmaceuticals and digital therapies addressing unmet needs within the space of substance use disorders and mental health. The products are commercialized by Orexo in the USA or via partners worldwide. The main market is the American market for buprenorphine/naloxone products, where the company commercializes its product Zubsolv for treatment of opioid use disorder. The head office, where research and development is also performed, is situated in Uppsala, Sweden.Orexo AB is a pharmaceutical corporation engaged in developing pharmaceutical products based on proprietary drug delivery technology. Its focus is on opioid dependence and pain but is also intended to address other therapeutic areas.

Latest ORX news

Currently there for this company. Visit our news hub for other news .